Chao Hua-Chuan, Chou Cheng-Ta, Lee Yi-Chung, Lin Kon-Ping
Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC; Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.
Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC; Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC; Brain Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.
J Neurol Sci. 2015 Nov 15;358(1-2):213-20. doi: 10.1016/j.jns.2015.08.1539. Epub 2015 Aug 29.
Charcot Marie Tooth disease type 1A (CMT1A) is the most commonly inherited demyelinating polyneuropathy with variable phenotypes, affected by several comorbidities, especially diabetes mellitus (DM). Previous studies showed that DM exacerbates the clinical manifestations of CMT1A.
We retrospectively evaluated patients with CMT1A in our hospital, and identified three groups among 12 cases, which comprised four patients with CMT1A, four with CMT1A+DM, and four with DM. We reviewed the CMT neuropathy score (CMTNS), electrophysiological data, and histomorphological parameters of the sural nerve, including fiber density, myelin thickness, axon diameter, g-ratio, regenerative clusters, and regeneration ratio.
The CMTNS was significantly higher in patients with CMT1A+DM (21.5±2.52) than in those with CMT1A only (10.8±4.4; p=0.03). Pathological findings in patients with CMT1A+DM included a significant decrease of myelinated fiber density (p=0.02) and reduction in the regenerative ratio (p=0.01), indicating severe degeneration with impaired regeneration. In non-parametric analyses, DM was found to play a more important role than CMT1A in influencing nerve degeneration and regeneration.
In patients with CMT1A, DM exacerbated clinical and pathological manifestations including increased loss of myelinated fibers, abnormal axon-myelin interaction, and impaired nerve regeneration.
1A型夏科-马里-图斯病(CMT1A)是最常见的遗传性脱髓鞘性多发性神经病,其表型多样,受多种合并症影响,尤其是糖尿病(DM)。既往研究表明,糖尿病会加重CMT1A的临床表现。
我们对我院的CMT1A患者进行了回顾性评估,在12例患者中确定了三组,其中包括4例CMT1A患者、4例CMT1A合并糖尿病患者和4例糖尿病患者。我们回顾了CMT神经病变评分(CMTNS)、电生理数据以及腓肠神经的组织形态学参数,包括纤维密度、髓鞘厚度、轴突直径、g比值、再生簇和再生率。
CMT1A合并糖尿病患者的CMTNS(21.5±2.52)显著高于仅患有CMT1A的患者(10.8±4.4;p=0.03)。CMT1A合并糖尿病患者的病理结果包括有髓纤维密度显著降低(p=0.02)和再生率降低(p=0.01),表明存在严重变性且再生受损。在非参数分析中,发现糖尿病在影响神经变性和再生方面比CMT1A起更重要的作用。
在CMT1A患者中,糖尿病会加重临床和病理表现,包括有髓纤维丢失增加、轴突-髓鞘相互作用异常以及神经再生受损。